Results for tag: "Growth Hormone Antagonist"

The Growth Hormone Antagonist market is a segment of the Endocrine and Metabolic Disorders Drugs market. Growth Hormone Antagonists are drugs used to treat conditions such as acromegaly, a disorder caused by excessive growth hormone production. These drugs work by blocking the action of growth hormone, thereby reducing its effects. Commonly used Growth Hormone Antagonists include pegvisomant, lanreotide, and octreotide. These drugs are administered via injection and are typically used in combination with other treatments such as surgery and radiation therapy. Growth Hormone Antagonists are used to treat a variety of endocrine and metabolic disorders, including acromegaly, Cushing's syndrome, and hyperthyroidism. They are also used to treat certain types of cancer, such as neuroendocrine tumors. Some companies in the Growth Hormone Antagonist market include Pfizer, Novartis, and Ipsen. Show Less Read more